Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts

Full text for this resource is not available from the Research Repository.

Akiyama, Toru, Dass, Crispin R, Shinoda, Y, Kawano, H, Tanaka, Sakae and Choong, Peter F. M (2010) Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts. Journal of Pharmacy and Pharmacology, 62 (4). pp. 470-476. ISSN 0022-3573

Item type Article
URI https://vuir.vu.edu.au/id/eprint/7570
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 0304 Medicinal and Bimolecular Chemistry
Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions)
Keywords ResPubID21865. osteoclast, osteosarcoma, bone cancer, RANK, RANKL, tumours, protein therapy
Citations in Scopus 24 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login